Lab bate and Doug las re cently de scribed the use of ol an zap ine to treat a pa tient with post trau matic stress dis or der (PTSD)(1). The mood and anxi ety symp toms were con trolled, but the patient suf fered from night mares and sleep dis tur bances. We pres ent 2 cases wherein ol an zap ine was used early in the phar ma col ogi cal treat ment of PTSD.
Pa tient 1 is a 25-year-old woman, di agnosed at age 23 years with PTSD, who as a child was sexu ally as saulted by an older woman. Her sex ual ori en ta tion was ex clu sively het ero sex ual, and her sex ual re la tion ship with her hus band was de scribed as ful fill ing. Her con dition had been man aged suc cess fully with cognitive-behavioural ther apy with a com mu nity so cial worker, but she suffered a re lapse while un der go ing treatment for in fer til ity. Most dis turb ing to her were in tru sive, ego-dystonic thoughts and im ages of a ho mo sex ual na ture. Treated as an out pa tient with fluvox am ine up to 400 mg daily for 2 weeks by her fam ily phy si cian, her distress in creased to the point where she became sui ci dal and re quired ad mis sion. In re sponse to the in creas ing in ten sity of her ego-dystonic im ages, she was started on a trial of ol an zap ine 2.5 mg at bedtime. Within 2 days she re ported that both the fre quency and in ten sity of the im ages had de creased, and she was discharged 10 days af ter start ing ol an zapine. She con tin ues to take fluvox am ine 400 mg daily and to at tend for psy cho ther apy.
Pa tient 2 is a 45-year-old woman who was sexu ally as saulted as a 12-year-old by her then 18-year-old brother. Af ter her daugh ter was sexu ally as saulted, she de vel oped symp toms that in cluded flash backs, emo tional numb ing, dere aliza tion, marked hy per vigilence, avoidance of men who re sem bled her brother, and sui ci dal idea tions. Un til her daugh ter's as sault, she had no symp toms and no rec ol lec tion of her own as sault. She saw a psy cholo gist in the com munity for de pres sion, but she did not disclose her PTSD symp toms at that time. She took a leave of ab sence from work and was ad mit ted af ter a sui cide at tempt. She was treated with par oxet ine, reaching 40 mg daily 2 days be fore ad mis sion. Af ter ad mis sion, she dis closed the history of the sex ual as sault and her symptoms and was started on ol an zap ine 2.5 mg at bed time. Two days af ter start ing ol an zap ine, she re ported a de crease in her PTSD symp toms and was no longer sui ci dal. She was able to dis cuss her assault openly and re sumed ther apy with her out pa tient psy cholo gist.
These cases dem on strate that ol an zapine, along with other second-generation an tipsy chot ics, may have ef fi cacy in treat ing not only those pa tients with PTSD who ex pe ri ence chronic re sid ual symp toms (1-3) but also those in the acute phase of phar ma col ogi cal treatment. An analo gous pro to col is the use of ben zo di azepines in the treat ment of other anxi ety dis or ders while serotonin-specific re up take in hibi tors (SSRIs) are be ing ti trated and dur ing the pe riod be fore clini cal ef fects are noted. It is pos si ble that the re sponse seen in these pa tients re flects the ac tions of the SSRIs, but the rapid and tem po ral re lation be tween the ini tia tion of ol an zap ine and the de crease within days in in tru sive thoughts and vis ual im agery de scribed by the pa tients strongly sug gests that this medi ca tion was in volved.
Trevor I Prior, BSc(Hons), MD, PhD, FRCP(C) Edmonton, Alberta
Re: Treatment of Posttraumatic Stress Disorder With Olanzapine

Dear Edi tor:
We read with in ter est the case re ports writ ten by Dr Prior. The salu tary ef fect of ol an zap ine on the re-experiencing symp toms of post trau matic stress dis order (PTSD) in these 2 acute cases comports with our find ing of simi lar im prove ment in a pa tient with chronic PTSD. These com pel ling cases sug gest that ol an zap ine may be a use ful ad junct in the com plex treat ment of PTSD, although placebo-controlled tri als are needed to de ter mine the short-and long-term ef fi cacy of ol an zap ine on reexperiencing symp toms.
Lawrence A Labbate, MD Susan Douglas, MD Charleston, South Carolina
Quetiapine-Associated Hypomania in a Woman With Schizoaffective Disorder
Dear Edi tor:
I re port the first case of a woman with schi zoaf fec tive dis or der (de pres sive type) who had an epi sode of hy po ma nia as so ci ated with the atypi cal an tipsychotic queti apine (no simi lar re ports were found on MED LINE).
A 43-year-old woman di ag nosed with DSM-IV schi zoaf fec tive dis or der (depres sive type) at age 27 years had for years had a sta ble clini cal pic ture (negative symp toms) while tak ing fluoxet ine 20 mg daily, chlor pro maz ine 100 mg daily, and di aze pam 5 mg daily. Dur ing a follow-up visit, she com plained of mild in som nia and weight gain. Her mood was nor mal, and she was not psychotic. Chlor pro maz ine was dis con tinued, and queti apine 100 mg daily was added at night. Over the course of 1 week, queti apine was in creased to 300 mg daily. Dur ing the fol low ing 4 weeks, she had in creased dif fi culty sleep ing, 
